The tumor-selective viral protein apoptin effectively kills human biliary tract cancer cells

Author： Pietersen Alexandra   Rutjes Saskia   Tongeren Joost   Vogels Ronald   Wesseling John   Noteborn Mathieu  

Publisher： Springer Publishing Company

ISSN： 0946-2716

Source： Journal of Molecular Medicine, Vol.82, Iss.1, 2004-01, pp. : 56-63

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Plasma‐activated medium (PAM) kills human cancer‐initiating cells

By  

PATHOLOGY INTERNATIONAL, Vol. 68, Iss. 1, 2018-01 ,pp. : 23-30

John Wiley & Sons Inc

Access to resources Recommend Favorite

Novel diagnostic and prognostic biomarkers in biliary tract cancer

By Skipworth James RA   Timms John F   Pereira Stephen P  

Expert Opinion on Medical Diagnostics, Vol. 7, Iss. 5, 2013-09 ,pp. : 487-499

Informa Healthcare

Access to resources Recommend Favorite

Time to Move to Targeted Drugs in Biliary Tract Cancer?

By  

Oncology Research and Treatment, Vol. 33, Iss. 1-2, 2010-01 ,pp. : 10-11

Karger

Access to resources Recommend Favorite

S-1 Monotherapy in Patients with Advanced Biliary Tract Cancer

By  

Oncology, Vol. 77, Iss. 1, 2009-06 ,pp. : 71-74

Karger

Access to resources Recommend Favorite

Patterns of Initial Disease Recurrence after Resection of Biliary Tract Cancer

By  

Oncology, Vol. 83, Iss. 2, 2012-07 ,pp. : 83-90

Karger

Access to resources Recommend Favorite